Registry of Outcomes of Dezawa MuseCells®
MuseCell Innovations Pte LTD
Summary
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases. The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
Description
Multilineage-Differentiating Stress-Enduring (MUSE) cells represent a unique and promising class of endogenous, non-tumorigenic pluripotent-like stem cells. First identified and characterized by Professor Mari Dezawa and her team in 2010, these cells are a naturally occurring somatic stem cells found in the bone marrow, connective tissues of various adult organs, including adipose tissue and dermis, as well as in the peripheral blood. MUSE cells exhibit a "double-feature" profile, combining the most desirable attributes of both pluripotent stem cells like embryonic stem cells and adult mesench…
Eligibility
- Age range
- Up to 89 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Received Dezawa MuseCells® as Part of Routine Clinical Care 2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up. 3. Willingness to Complete Online Survey Assessments 4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period. 5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic…
Interventions
- OtherMuseCell Treatment
Patients undergoing treatment with Dezawa MuseCells
Locations (2)
- Bioreset MedicalNorth Palm Beach, Florida
- Regene LabsGuadalajara